Omeros Corporation

États‑Unis d’Amérique


 
Quantité totale PI 302
Rang # Quantité totale PI 4 264
Note d'activité PI 3,1/5.0    190
Rang # Activité PI 3 626
Symbole boursier
ISIN US6821431029
Capitalisation 659M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

112 34
64 7
59 11
15
 
Dernier brevet 2025 - Pde 7 modulator compounds
Premier brevet 1995 - Tendon and ligament repair system
Dernière marque 2024 - YARTEMLEA
Première marque 2001 - OMEROS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Biological preparations for the treatment of endothelial diseases and disorders, renal diseases, ...
Invention Pde 7 modulator compounds. Compounds having activity as modulators of phosphodiesterase 7 (PDE 7...
Invention Pde 7 modulator compounds. Compounds having activity as modulators of phosphodiesterase 7 (PDE 7)...
P/S Biochemical preparations for medical purposes, namely, for the treatment of endothelial diseases ...
Invention Masp-2 inhibitors and methods of use. The present disclosure provides, inter alia, compounds wit...
P/S Biological and pharmaceutical preparations for the treatment of transplant complications, ischemi...
P/S Pharmaceutical preparations for complement-mediated diseases, addiction and oncology, none of the...
Invention Methods for treating conditions associated with masp-2 dependent complement activation. In one a...
Invention Methods for inhibiting fibrosis in a subject in need thereof. In one aspect, the invention provi...
Invention Methods for inhibiting angiogenesis in a subject in need thereof. In one aspect, the present inv...
P/S Biochemical preparations for medical purposes, namely, for the treatment of endothelial diseases...
P/S Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal disea...
P/S Pharmaceutical preparations for complement-mediated diseases, addiction and oncology
P/S Medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals, ...
Invention Methods for treating and/or preventing idiopathic pneumonia syndrome (ips) and/or capillary leak...
2023 Invention Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrha...
Invention Antibodies specifically binding to masp-3 for the treatment of various diseases and disorders. T...
Invention Masp-2 inhibitors and methods of use. The disclosure provides synthetic compositions useful as i...
Invention Fused pyrimidines as masp-2 inhibitors. The disclosure provides synthetic compositions useful as ...
Invention Therapeutic methods and uses for antibodies to human masp-3. Methods of treating paroxysmal noct...
Invention Therapeutic methods and uses for antibodies to human masp-3. Methods of treating paroxysmal noctu...
Invention Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods of t...
Invention Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of va...
P/S Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseas...
Invention Methods and compositions for treating cancer. This disclosure is directed to compounds, composit...
Invention Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof. Isolat...
P/S Medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals,...
P/S Biological and pharmaceutical preparations for the treatment of transplant complications, ischem...
Invention Masp-2 and masp-3 inhibitors, and related compositions and methods, for treatment of sickle cell ...
Invention Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods. Th...
Invention Compositions for inhibiting masp-2 dependent complement activation. The present invention relate...
2022 Invention Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof. Isola...
Invention Masp-2 inhibitors and methods of use. The present disclosure provides, inter alia, compounds with...
P/S Providing information concerning medical and scientific research with respect to transplant compl...
Invention Compositions and methods of inhibiting masp-2 for the treatment of various thrombotic diseases an...
Invention Inhibitors of gpr174 and uses thereof. GPR174 is an orphan receptor that has been implicated in ...
Invention Targeted catalytic complement-activating molecules and methods of use thereof. In one aspect, th...
Invention Targeted catalytic complement-activating molecules and methods of use thereof. In one aspect, the...
Invention Methods and compositions for treating cancer. Compounds, compositions, and methods for generatin...
Invention Methods and compositions for treating cancer. Compounds, compositions, and methods for generating...
P/S Providing medical and scientific research information in the fields of pharmaceuticals and bioph...
P/S Providing medical and scientific research information in the fields of pharmaceuticals and biopha...
Invention Treatment of addiction and impulse-control disorders using pde7 inhibitors. This disclosure is d...
Invention Chimeric inhibitor molecules of complement activation. The present invention relates to novel chi...
P/S Printed publications in the nature of brochures, pamphlets, newsletters, written articles and gui...
P/S Medical information services, namely, providing information concerning pharmaceutical and biophar...
Invention Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19. Disclosed...
Invention Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19. Disclosed ...
2021 Invention Ophthalmologic irrigation solutions and method. Solutions for perioperative intraocular applicat...
Invention Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of pa...
2020 P/S Research and development in the pharmaceutical and biotechnology fields; providing medical and sc...
2019 P/S Pharmaceuticals and pharmaceutical preparations; biologics.
P/S Pharmaceutical preparations containing pharmacologic agents for the inhibition of pain, inflamma...